Main > ONCOLOGY (**) > Leukemia>Lymphoblastic>Acute>Ph+*** > Treatment > Co.: USA. B. Brand Dasatinib *

---

Co.: USA. B. Brand Dasatinib *'s subsections
(*) USA Approval Date: 2006. 06.29
Company
Patent>Assignee; Claims; No.; Etc.
Patent>UpDate: 2007. 01.23
Patent>US Expiration: 2020. 04.03
TradeMark
TradeMark Web-Site

Co.: USA. B. Brand Dasatinib *'s products
This section has no products